Irreversible electroporation for selected men with intermediate-risk, localized prostate cancer — first in the DMV, performed in a surgery center.
TIME named the AngioDynamics NanoKnife one of its Best Inventions of 2025. Cleared by the FDA in December 2024, it gives men with intermediate-risk prostate cancer a minimally invasive option before radiation or traditional surgery, treatments that can damage the nerves nearby.
I was the first surgeon in the DMV to perform NanoKnife IRE for prostate cancer in a surgery center.
Source: TIME Best Inventions of 2025 — AngioDynamics NanoKnife
NanoKnife IRE suits selected men with intermediate-risk, localized disease — not everyone. A workup including MRI-fusion biopsy determines candidacy.